Search research articles
Contact Us
Filters
Showing results (81-90 of 126) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study
Xavier Bertagna, Rosario Pivonello, Maria Fleseriu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 26, 2006
Prognostic parameters of metastatic adrenocortical carcinoma
Guillaume Assié, Guillemette Antoni, Frédérique Tissier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
Rossella Libé, Amato Fratticci, Joel Coste, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 25, 2011
Clinical and pathophysiological implications of chromosomal alterations in adrenocortical tumors: an integrated genomic approach
Olivia Barreau, Aurélien de Reynies, Hortense Wilmot-Roussel, et al.
European Journal of Endocrinology
|
December 19, 2013
Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas
Bruno Ragazzon, Rossella Libé, Guillaume Assié, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2010
Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers
Sébastien Gaujoux, Stéphane Pinson, Anne-Paule Gimenez-Roqueplo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 25, 2012
Identification of a CpG island methylator phenotype in adrenocortical carcinomas
Olivia Barreau, Guillaume Assié, Hortense Wilmot-Roussel, et al.
Cancer Research
|
September 6, 2005
Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors
Frédérique Tissier, Catherine Cavard, Lionel Groussin, et al.
European Journal of Endocrinology
|
July 5, 2007
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas
Laure Cazabat, Rossella Libè, Karine Perlemoine, et al.
European Journal of Endocrinology
|
August 6, 2015
The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas
Claire Chambre, Emily McMurray, Camille Baudry, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 126) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study
Xavier Bertagna, Rosario Pivonello, Maria Fleseriu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 26, 2006
Prognostic parameters of metastatic adrenocortical carcinoma
Guillaume Assié, Guillemette Antoni, Frédérique Tissier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
Rossella Libé, Amato Fratticci, Joel Coste, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 25, 2011
Clinical and pathophysiological implications of chromosomal alterations in adrenocortical tumors: an integrated genomic approach
Olivia Barreau, Aurélien de Reynies, Hortense Wilmot-Roussel, et al.
European Journal of Endocrinology
|
December 19, 2013
Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas
Bruno Ragazzon, Rossella Libé, Guillaume Assié, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2010
Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers
Sébastien Gaujoux, Stéphane Pinson, Anne-Paule Gimenez-Roqueplo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 25, 2012
Identification of a CpG island methylator phenotype in adrenocortical carcinomas
Olivia Barreau, Guillaume Assié, Hortense Wilmot-Roussel, et al.
Cancer Research
|
September 6, 2005
Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors
Frédérique Tissier, Catherine Cavard, Lionel Groussin, et al.
European Journal of Endocrinology
|
July 5, 2007
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas
Laure Cazabat, Rossella Libè, Karine Perlemoine, et al.
European Journal of Endocrinology
|
August 6, 2015
The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas
Claire Chambre, Emily McMurray, Camille Baudry, et al.
Page
of 13